322M 12.5/500 (Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 500 mg)
Pill with imprint 322M 12.5/500 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 500 mg. It is supplied by Perrigo New York Inc..
Alogliptin/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Alogliptin/metformin 12.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 322M 12.5/500
Alogliptin Benzoate and Metformin Hydrochloride
- Imprint:
- 322M 12.5/500
- Strength:
- 12.5 mg / 500 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0169
More about alogliptin/metformin
- Alogliptin/metformin Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Drug class: antidiabetic combinations
- FDA Alerts (4)
Consumer resources
Other brands: Kazano
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
